Monday, January 23, 2017 8:31:28 PM
Big Pharma and BIEL? Whatever would make one think that? If any Big Pharma wanted BIEL it could have it now for peanuts. In fact, the same will be true if FDA approval materializes. The company has little of value outside the product - Big Pharma certainly wouldn't need BIEL distribution agreements - or anything else of BIEL's for that matter.
Big Pharma might open its checkbook, but not much would come out of it.... FDA approval for a product currently available to many millions overseas with minimal sales. Hardly worth a fortune to Big Pharma - and certainly at .0002 - not much to shareholders but endless hope and hype.
You know when - since 2009
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM